Zevra Therapeutics

About:

Zevra Therapeutics is a biopharmaceutical company focused on discovering and developing therapies for pain, ADHD, and other CNS diseases.

Website: https://zevra.com/

Twitter/X: zevratx

Top Investors: Deerfield, HealthCare Royalty Partners, Perceptive Advisors, BP Growth Partners

Description:

Zevra Therapeutics is a development-stage biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. The company’s primary efforts include the development of safer, abuse-resistant opioid pain relievers. Its drug discovery and development platform is based on its proprietary Ligand Activated Therapy (LAT) approach. KemPharm uses its patent-applied technology to improve existing drugs and shorten the development timeline while still maintaining a strong intellectual property position within each therapeutic area.